In vitro susceptibilities of bloodstream isolates of Candida species to six antifungal agents: results from a population-based active surveillance programme, Barcelona, Spain, 2002–2003 | Zendy

Manuel CuencaEstrella | Zendy; Dolores Rodriguez | Zendy; Benito Almirante | Zendy; Juliette Morgan | Zendy; Ana María Planes | Zendy; Manel Almela | Zendy; José Mensa | Zendy; F Sánchez | Zendy; Josefina Ayats | Zendy; Montserrat Giménez | Zendy; Margarita Salvadó | Zendy; David W. Warnock | Zendy; Albert Pahissa | Zendy; Juan L. Rodrı́guez-Tudela | Zendy

Open Access

In vitro susceptibilities of bloodstream isolates of Candida species to six antifungal agents: results from a population-based active surveillance programme, Barcelona, Spain, 2002–2003

Author(s) -

Manuel CuencaEstrella,

Dolores Rodriguez,

Benito Almirante,

Juliette Morgan,

Ana María Planes,

Manel Almela,

José Mensa,

F Sánchez,

Josefina Ayats,

Montserrat Giménez,

Margarita Salvadó,

David W. Warnock,

Albert Pahissa,

Juan L. Rodrı́guez-Tudela

Publication year - 2004

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkh548

Subject(s) - microbiology and biotechnology , antifungal , population , biology , bloodstream infection , antibacterial agent , medicine , antibiotics , environmental health

The antifungal drug susceptibilities of 351 isolates of Candida species, obtained through active laboratory-based surveillance in the period January 2002-December 2003, were determined (Candida albicans 51%, Candida parapsilosis 23%, Candida tropicalis 10%, Candida glabrata 9%, Candida krusei 4%).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research